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ABSTRACT.
Purpose: To determine whether excimer laser ablation of guttae is a viable
strategy for removal of diseased tissue in Fuchs’ endothelial corneal dystrophy
(FECD) on excised human Descemet membranes and whether an excimer laser-
created wound on healthy human corneas ex vivo is recolonized with corneal
endothelial cells.
Methods: Descemet membranes of FECD patients and corneal endothelium of
normal human corneas were ablated ex vivo using an excimer laser licensed for
glaucoma surgery. Specimens were kept in cell culture medium supplemented
with 10 lM of rho-kinase inhibitor ripasudil. Corneal endothelial cell regener-
ation was observed using light and electron scanning microscopy. Furthermore,
the whole corneal samples were evaluated by haematoxylin/eosin staining and
immunohistochemical analysis using antibodies against Na+/K+-ATPase.
Results: Guttae and corneal endothelium could be ablated with an excimer laser
without total ultrastructural damage to the Descemet membrane or stroma.
Nearly complete endothelial wound closure was accomplished after 26–38 days
in treated corneas. Light and electron scanning microscopy suggested the
establishment of a layer of flat endothelial cells. Additionally, Na+/K+-ATPase
expression could only be observed on the inner side of the Descemet membrane.
Conclusion: Our proof of concept study demonstrated that excimer lasers can be
used to ablate diseased tissue from excised FECD Descemet membranes ex vivo.
Additionally, corneal endothelial cells recolonize a previously ablated endothelial
area in healthy human corneas ex vivo under treatment with ripasudil. Thus, our
results are the first experimental basis to further investigate the feasibility of an
excimer laser ablation as a graftless FECD treatment option.
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Introduction
Fuchs’ endothelial corneal dystrophy
(FECD) is the most common dystrophy
of the corneal endothelium leading to a
significant decline in visual acuity. A
gradual loss of endothelial cells leads to
reduced corneal deturgescence via loss
of Na+/K+-ATPase density (McCartney
et al. 1987; McCartney et al. 1989) with
subsequent corneal oedema (Elhalis
et al. 2010) and opacity (Borboli &
Colby 2002).
As Fuchs’ endothelial corneal dys-
trophy develops, the characteristic pro-
teinaceous lesions known as guttae
accumulate as excrescences on
the Descemet membrane (Abbott
et al. 1981). In early stages, they may
produce light scatter and visual blur,
when confluent and enlarged, they are
not compatible with endothelial cell
homeostasis and lead to cell death.
This effect may be size related, with
large guttae presenting an insurmount-
able challenge to cell monolayer for-
mation. Guttae typically follow a
centrifugal distribution pattern with
peripheral involvement in advanced
disease stage (Elhalis et al. 2010). By
electron microscopy, Descemet mem-
branes in FECD show a typical addi-
tional posterior banded layer (PBL)
consisting of dense fibrillary compo-
nents and collagen compared with
normal Descemet membranes (Xia
et al. 2016). Furthermore, electron
microscopy reveals a banded structure
within guttae. With regard to the
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ultrastructure of guttae, there are many
hypotheses, but the exact mechanisms
of PBL and gutta formation are
unclear. One hypothesis suggests
unknown processes may lead to a
transformation of endothelial cells to
a fibroblast-like phenotype, secreting
collagen fibrils and thus forming the
PBL. Focal accelerations of those
transformation processes are suggested
to lead to guttae (Iwamoto & DeVoe
1971; Adamis et al. 1993).
State-of-the-art treatment of FECD
is the endothelial keratoplasty. The
predominant forms remain Descemet
stripping endothelial keratoplasty
(DSEK), where the diseased host Des-
cemet membrane and endothelium are
removed and replaced through donor
endothelial cells and an additional stro-
mal layer (Wacker et al. 2016), and
Descemet membrane endothelial ker-
atoplasty (DMEK; Dapena et al. 2013).
First described by Melles et al. (2006),
DMEKdiffers fromDSEKby replacing
the abnormal Descemet membrane and
endothelium without any stromal graft
leading to a significantly faster recovery
of visual acuity (Price et al. 2009).
The demand for corneal grafts
worldwide is continuously rising, in
particular for the treatment of Fuchs’
endothelial corneal dystrophy. Accord-
ing to recent figures, FECD is the
number one indication for corneal
transplantation worldwide. In 2012,
39% of all corneal grafts were used
for the treatment of FECD (Gain et al.
2016). In light of anecdotal evidence
suggesting some regenerative capacity
of the native endothelium (Dirisamer
et al. 2011), and in need of a graft free
alternative, many groups came up with
a novel procedure: Descemet stripping
without endothelial keratoplasty
(DWEK; Moloney et al. 2015). In
brief, corneal clearance is achieved
following a manual descemetorhexis
without using any donor tissue (Shah
et al. 2012; Bleyen et al. 2013). This
approach is further encouraged by
recent studies reporting a positive effect
of rho-associated kinase (ROCK) inhi-
bitor ripasudil on corneal wound heal-
ing. In rabbits, Okumura et al. (2015)
showed a significant increase in corneal
clearance after damage of the corneal
endothelium following topical treat-
ment with the ROCK inhibitor Y-
27632. Those findings are in line with
Moloney et al. (2017), who observed an
acceleration of corneal clearance in
FECD patients treated with topical
ripasudil following manual desceme-
torhexis. Overall, there is strong evi-
dence that corneal endothelial cells
(CEC) have the distinct potential to
regenerate or migrate after removal of
the Descemet membrane in FECD.
At present, therefore, it has been
demonstrated that surgical removal of
guttae along with their basement mem-
brane improves visual acuity in FECD
(Shah et al. 2012; Bleyen et al. 2013;
Okumura et al. 2015; Moloney et al.
2017). Once this wound is created,
however, cells in the peripheral cornea
must migrate across to restore a func-
tional cell layer, with or without the
encouragement of ROCK inhibition. It
has also been demonstrated in vitro
that this process is faster and more
reliable if the underlying basement
membrane (Descemet membrane) is
left intact (Okumura et al. 2018; Soh
& Mehta 2018). In addition, in vivo
experience of DWEK surgery has
demonstrated that injury to underlying
stromal tissue may result in unfavour-
able healing response (Garcerant et al.
2019).
The surgical challenge presenting
itself therefore is to determine whether
it is possible to remove guttae from the
posterior cornea while preserving the
underlying Descemet membrane. The
guttae themselves are outgrowths of
protein, tightly bound to the mem-
brane and not easily removed. An
excimer laser which photoablates tissue
is an ideal tool to smooth the posterior
cornea profile and allow uninterrupted
migration and monolayer formation of
endothelial cells.
Excimer lasers are gas lasers emit-
ting ultraviolet light, which are used in
corneal surgery since 1983 (Trokel
et al. 1983). Commonly a pulsed laser
beam with a very short pulse duration
is applied to the desired corneal tissue.
Nevertheless, the focal energy output is
high. Different parameters contribute
to the outcome of laser ablation, espe-
cially the wavelength, pulse duration
and spot diameter (Verma et al. 2017).
The pulse energy essentially influences
the area and depth of corneal ablation
by a single pulse (Arba Mosquera &
Verma 2015). Besides refractive sur-
gery, excimer lasers are nowadays used
in a broad field of ophthalmic surgical
procedures, including minimally inva-
sive glaucoma surgery (Wilmsmeyer
et al. 2006).
The aim of our current ex vivo study
was to investigate whether the ablation
of guttae by an excimer laser is possible
and whether an ablation of the corneal
endothelium of healthy human corneas




Sclerocorneal rings not suitable for
corneal transplantation due to lack of
sufficient endothelial cell count or pos-
itive microbiological testings were
obtained from the Bavarian tissue bank
(Munich, Germany). None of the
donors had any previous eye disease.
Human tissue was secured in a humane
fashion compliant with the Declaration
of Helsinki following approval by the
local ethics committee (approval ID:
73416). Descemet membranes were
received with consent from FECD
patients undergoing Descemet mem-
brane endothelial keratoplasty.
Both types of tissue were stored in
uncoated cell culture plastic (NUNC,
Langenselbold, Germany) and kept in
culture medium (Dulbecco’s MEM;
Biochrom GmbH, Berlin, Germany)
supplemented with 10% fetal calf
serum (Biochrom GmbH), 50 IU peni-
cillin/ml and 50 µg streptomycin/ml at
37°C and 5% carbon dioxide.
Excimer laser
All experiments were conducted with a
modified ExTra ELT excimer laser
(MLase AG, Germering, Germany)
with a pulsed beam emitting light of
308 nm and a pulse duration of 60–
120 ns. The laser was previously
licensed for minimally invasive glau-
coma surgery. Laser beam output at
the desired destination was maintained
by a fibre optical laser applicator
(FIDO, MLase AG).
Corneal endothelium and guttae ablation
procedure
Following epithelial abrasion, sclero-
corneal rings were mounted onto a cell
culture plastic with the corneal endothe-
lium facing up. Staining of the wounded
corneal endothelial area was conducted
with trypan blue (VisionBlue; D.O.R.C.




Descemet membranes were flat
mounted and pinned onto cell culture
plastic dishes with entomological pins
(Ento Sphinx s.r.o., Pardubice, Czech
Republic). To simulate physiological
conditions, sodium hyaluronate (Hea-
lon PRO; Johnson & Johnson, New
Brunswick, NJ, USA) was injected
between the Descemet membrane and
the cell culture plastic followed by
staining with trypan blue.
Excimer laser treatment included
step-by-step circular guttae ablation
involving the central 4 mm of the
corneal endothelium and the Descemet
membrane, avoiding impact on the
basal membrane of the same and with-
out direct tissue contact. In addition, in
sclerocorneal rings a corridor heading
to the limbus was formed to facilitate
migration of corneal endothelial cells
out from the peripheral endothelium.
Centrally, besides a superficial abla-
tion, a deep wound to stromal tissue
was created intentionally to investigate
the effect of an accidental damage to
the corneal stroma. The whole proce-
dure was conducted on three human
corneas.
Light and electron scanning microscopy
Sclerocorneal rings and Descemet
membranes were analysed and photo-
documented weekly using a stereo
microscope (Stemi 508; Carl Zeiss AG,
Jena, Germany) following staining with
trypan blue.
Before electron scanning micro-
scopy, corneas were fixed in a cacody-
late-buffered solution containing 4%
paraformaldehyde (PFA) and 4% glu-
taraldehyde for 24 hr. Subsequent to
washing with cacodylate buffer and
dehydration in ascending ethanol and
acetone series, the samples were critical
point dried and sputter coated with
gold-palladium. Images were captured
with an Auriga scanning electron
microscope (Carl Zeiss AG).
To assess whether recolonized cor-
neal endothelial cells expand on
wounded area, the cell area of 60
CEC of three corneas were measured
in IMAGEJ (ImageJ 1.50c4; National
Institute of Health, Bethesda,
MD, USA). Comparison was made
between regular endothelial cells in
unaffected areas of the cornea and
those cells colonized on the previously




were sliced into center-involving eighth
and fixed with 4% PFA for 4 hr, fol-
lowed by embedding in paraffin accord-
ing to standard procedures. Meridional
sections of the corneas were stained with
haematoxylin and eosin and analysed by
light microscopy on an Axiovision
microscope (Carl Zeiss AG).
For immunostaining against the
endothelial Na+/K+-ATPase, sections
were hydrated and washed with 0.1 M
phosphate buffer at room temperature
for 10 min and blocked with 3%
bovine serum albumin (BSA) and
0.1% Triton X-100 in 0.1 M phosphate
buffer for 60 min followed by an incu-
bation with anti-mouse Na+/K+-
ATPase antibodies (1:50; Novus Bio-
logicals, Wiesbaden, Germany) in
0.3% BSA and 0.01% Triton X-100
in 0.1 M phosphate buffer for 24 hr at
4°C. Following three washing cycles
with 0.1 M phosphate buffer, Alexa488-
coupled anti-mouse antibodies (1:1000;
ThermoFisher Scientific, Waltham,
MA, USA) were added for 60 min.
After final incubation, samples were
washed three times with 0.1 M phos-
phate buffer 10 min each and were
mounted with fluorescent mounting
medium containing 1:50 4’,6-di-
amidino-2-phenylendole (DAPI; Vec-
tor Laboratories Inc., Burlingame, CA,




Quantification of endothelialized area
after trypan blue staining was con-
ducted by a semi-automated colour
threshold function in IMAGEJ. Data
analysis was conducted with Microsoft
Excel (Microsoft Office 365, Microsoft,
Redmond, WA, USA). Graphs were
plotted with PRISM 8 (GraphPad Soft-
ware, San Diego, CA, USA).
Results
Corneal endothelial cells migrate following
descemetorhexis
To investigate migratory capacity of
corneal endothelium, we conducted
manual descemetorhexis only on
human corneas ex vivo. Keeping them
in cell culture medium supplemented
with 10 µM of ripasudil for 2 days,
migration of endothelial cells from the
edges of the descemetorhexis into the
wounded area was observed by elec-
tron microscopy (Fig. 1A,B). The
corneal endothelial cells seemed to
migrate across the step formed by the
edge of the descemetorhexis onto cor-
neal stroma to re-establish corneal
endothelium.
Laser ablation of guttae and Descemet
membranes additional posterior banded
layer
To analyse whether the pulsed excimer
laser beam can ablate guttae and the
additional posterior banded layer of
the Descemet membrane of patients
suffering from FECD, preparations of
patients undergoing Descemet mem-
brane endothelial keratoplasty were
whole mounted on a cell culture dish
and stained with trypan blue prior to
ex vivo treatment. To test whether a
layer-by-layer removal ablation of
both diseased structures is possible,
the tip of the fibre optical laser
(A) (B)
Fig. 1. Electron scanning microscopy of regular human corneas following manual desceme-
torhexis. (A and B) Representative images of the corneal endothelium following manual
descemetorhexis. The arrows point at grouped corneal endothelial cells, appearing to span




applicator was carefully approached
until first laser effects could be
observed. By using this technique,
focal excrescences could be removed
with a high degree of precision
(Fig. 2A,B). In addition, the spongy
material of the additional posterior
banded layer of the Descemet mem-
brane could be removed in a layer-by-
layer manner without affecting the
subjacent normal Descemet membrane
(Fig. 2C,D).
Laser ablation of corneal endothelial cells
and Descemet membrane
To further examine whether the exci-
mer laser can ablate corneal endothelial
cells without destruction of the Desce-
met membrane, ex vivo human sclero-
corneal rings were stained with trypan
blue before laser treatment. By care-
fully approaching the tip of the fibre
optical laser applicator, the corneal
endothelium could be cleared without
removal of Descemet membrane
(Fig. 3A). Only a few ruptures in the
Descemet membrane were detected. In
areas where a targeted ablation was
wanted, the Descemet membrane was
removed completely and highly orga-
nized collagen bundles of the corneal
stroma were observed by scanning
electron microscopy (Fig. 3B).
Restoration of the corneal endothelium
following ablation
To test whether corneal endothelial
cells can migrate onto a laser wounded
area the endothelium and in part the
Descemet membrane of human ex vivo
corneas from healthy donors was laser-
ablated following trypan blue staining.
To further analyse whether a corridor
towards the trabecular meshwork
enhances migration of endothelial cells
from the periphery to the corneal
centre the circumscribed wound area
was extended to the periphery at the 12
o’clock position (Fig. 4A,B). Six days
after treatment, several small lighter
areas, which were located in a spot-like
manner adjacent to the unaffected
endothelium within the trypan blue
stained wound, were observed indicat-
ing an initial recolonization by corneal
endothelial cells under cell culture
conditions (Fig. 4C). In subsequent
weeks, the lighter areas extended, fused
with each other and nearly completely
closed after a maximum of 38 days
(Figs 4D–F and 5). Intriguingly,
2 weeks after laser ablation the broad-
est recolonized area was observed at
the 12 o’clock position suggesting that
the corridor might enhance migration
of corneal endothelial cells and hence
recovery of the corneal endothelium
(Fig. 4D).
Figure 5 indicates a re-endothelial-
ization of the ablated area starting
promptly postsurgery. Already after
6 days, corneal endothelial cells
migrated towards the wounded surface.
Migration continued steadily until days
13–19. Subsequently, a strong decline
of the exposed ablated surface could be
observed. A nearly complete closure of
the wounded area was achieved after
26–38 days (Fig. 5).
As we observed a wound closure of
the laser-ablated area in our ex vivo
experiments, we investigated morphol-
ogy and specificity of migrated cells by
light as well as electron scanning
microscopy and immunohistochem-
istry. On meridional sections of the
(A) (B)
(C) (D)
Fig. 2. Electron scanning microscopy of Fuchs’ endothelial corneal dystrophy (FECD) patients’
Descemet membranes before and after excimer laser ablation. Corneal endothelium and guttae
(arrows) could be ablated step-by-step without any microscopic damaging impact on the posterior
nonbanded layer (PNBL). Sub-panel A of Fig. 2 shows an electron microscopy image of an
untreated FECD patient. In comparison, B–D indicate ablated corneal endothelium and guttae. In
cross-section of the guttae and after complete corneal endothelium ablation, a fibrillary
spongiform structure became visible. The PNBL underneath seemed smooth and unaffected in
electron microscopy (indicated by the asterisk). Scale bars for A and D: 50 µm; B and C: 5 µm.
(A) (B)
Fig. 3. Ablation of the corneal endothelium and the Descemet membrane in regular human
corneas – electron scanning microscopy. (A) Displayed is an area after ablation of the corneal
endothelium only. Corneal endothelium seems bumpy and irregular, whereas the subjacent
Descemet membrane appears to be smooth after ablation of the endothelium. (B) Underneath the
ablated Descemet membrane, properly organized stromal collagen fibres emerge.
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cornea, a re-established Descemet
membrane, which is lined by flat
endothelial cells, was observed
(Fig. 6A). No specific signal for Na+/
K+-ATPases was detected in the cor-
neal stroma and epithelium, whereas
adjacent to the inner side of the
Descemet membrane specific staining
for Na+/K+-ATPases was observed
(Fig. 6B). Further on, no obvious
damage of the corneal stroma follow-
ing laser treatment was detected. In
line, by electron scanning microscopy a
dense monolayer of flat cells with a
central dome-shaped eversion was seen
(Fig. 6C). Quantification of cell size
demonstrates a significant 2.8-fold
increase of CEC surface in the
wounded area (1122.1  294.6 µm2)
when compared to unaffected resident
cells (398.3  49.6 µm2; p < 0.001),
suggesting that immigrated CEC
expand to cover the wounded area.
Overall, our data strongly suggest that
the inner corneal surface is recolonized
by endothelial cells.
Discussion
The challenge in DWEK surgery is
encouraging cell migration across a
bare stromal defect. ROCK inhibition
has been established as a probable aid
(A) (B) (C)
(D) (E) (F)
Fig. 4. Light microscopy of a regular human cornea after excimer laser treatment. (A and B) Postoperative images directly after treatment native and
stained with trypan blue. There is a clear boundary between intact corneal endothelium and ablated area. On 12 o’clock position a small corridor was
formed. (C–F): Displayed are analogous captures on days 6 (C), 13 (D), 20 (E) and 26 (F). The sub-panel of C shows small cell clusters beyond the
ablation border (asterisk).
Fig. 5. Re-endothelialization of ablated surface. The graph displays the remaining wound area in
percent of the initially ablated surface of human corneas ex vivo over time.
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in this process. Both Okumura and
Mehta have also suggested that an
intact basement membrane favours cell
migration (Okumura et al. 2018; Soh &
Mehta 2018). Mehta has even proposed
transfer of an acellular Descemet graft
to cover the bare stromal defect created
in DWEK surgery (Soh & Mehta
2018). Therefore, we chose to analyse
whether it is possible to remove guttae
while keeping the native basement
membrane intact.
Our findings showed that in FECD
Descemet membranes ex vivo, corneal
endothelium and guttae could be
ablated by a 308 nm excimer laser
clinically used in minimally invasive
glaucoma surgery. Furthermore, cor-
neal endothelial cells were able to
migrate centripetally after excimer laser
ablation from the periphery to the
centre of normal human corneas within
less than 4 weeks ex vivo. By histology
and immunostaining against Na+/K+-
ATPases, we could demonstrate that
corneal endothelial cells migrate on the
treated area to facilitate wound clo-
sure. For the corneal endothelium,
proliferation of a minor amount of
CEC close to the limbal area as well as
a continuous but slow centripetal
migration of CECs has been proposed
(He et al. 2012). In line, the significant
increase of the cell area of immigrated
CECs suggests cell expansion and thus
the conclusion that migration seems to
play a crucial role in regeneration of
corneal endothelium following central
ablation.
Corneal grafting and specifically
DMEK remains the gold standard
therapy in FECD (Dapena et al.
2009). The aim of this therapeutic
approach is to remove the damaged
corneal endothelium and replace it with
normal donor corneal endothelial cells.
Migration and regeneration of corneal
endothelial cells subsequently lead to
an increase of visual acuity (Dirisamer
et al. 2011). Excimer laser-aided
ablation of corneal endothelium in
human corneas ex vivo resulted in a
recolonization with corneal endothelial
cells. This is in keeping with recent
literature showing a similar effect of
manual descemetorhexis without
endothelial keratoplasty followed by
regeneration of the corneal endothe-
lium in the treatment of Fuchs’
endothelial corneal dystrophy. Still
there is a disadvantage of the so-called
DWEK procedure: the time until cor-
neal clearance and thus visual improve-
ment is significantly longer than in
DMEK (up to 10 weeks postopera-
tively without ROCK inhibition;
Huang et al. 2018). In comparison,
the conducted experiments showed a
corneal endothelial recolonization
within 5–6 weeks in cultured human
corneas. This may be due to preserva-
tion of the anterior layer of the
Descemet membrane serving as a fun-
dament for corneal endothelial cells to
migrate, as can be postulated by look-
ing at the electron microscopy. The
research group around Soh et al. (2016)
showed in several models in vitro that
endothelial cells migrate significantly
more efficient on a basement mem-
brane than on bare corneal stroma.
However, biomechanical properties of
Descemet’s membrane especially in
FECD are not yet completely under-
stood (Ali et al. 2016). Furthermore,
corneal endothelial cell migration
started from the preformed corridors
suggesting a better migration from the
periphery that cannot be established by
manual descemetorhexis.
Light and electron scanning micro-
scopy suggested a viable ablation of
guttae and corneal endothelium
ex vivo. To our knowledge, this is a
novel technique and application of
excimer lasers used in ophthalmology.
Currently, the removal of the Descemet
membrane in posterior lamellar ker-
atoplasty is accomplished through
manual descemetorhexis (Moloney
et al. 2017) including stripping off all
layers of the Descemet membrane. As
excimer laser ablation of the guttae-like
material is done layer by layer, the
anterior layer of the Descemet mem-
brane remains and acts as a smooth
scaffold for migrating endothelial cells.
Furthermore, excimer lasers are
already in use in ab interno trabeculo-
tomy (Wilmsmeyer et al. 2006) and for
smoothening the stromal part of donor
grafts prior to posterior lamellar
(A) (B)
(C)
Fig. 6. Immunohistochemistry and electron scanning microscopy after excimer laser ablation and
re-endothelialization. (A) Histological image of re-endothelialized previously ablated corneal
endothelium (haematoxylin and eosin staining). Scale bar: 50 µm. (B) Immunofluorescence.
Staining of endothelial Na+/K+-ATPase (green) and cell nuclei (blue). Scale bar: 50 µm. (C)
Electron scanning microscopy showing dome-shaped migrated corneal endothelial cells on the
wound area. Scale bar: 30 µm.
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keratoplasty (Cleary et al. 2012; Trinh
et al. 2013). A recent study showed no
significant difference of endothelial cell
density or corneal thickness before and
after femtosecond laser-assisted or
excimer laser-aided suture removal
after penetrating keratoplasty (Toth
et al. 2019) underlining the safety of
this technique.
To further examine the ultrastructure
of the Descemet membrane and guttae,
electron microscopy of the ablated
structures was conducted. Cut guttae
as well as the laser-affected corneal
endothelium showed a fibrillary spongy
structure with a subjacent smooth layer.
This might fit into the findings described
by Xia et al. (2016) suggesting that the
Descemet membrane in FECD patients
is set up by three layers: the posterior
banded layer (PBL), the posterior non-
banded layer (PNBL) and the anterior
banded layer (ABL).However, we could
not specifically distinguish the PNBL
and ABL in our analyses as we used
scanning electron microscopy, which
only illustrates the surface of the inner
cornea.Another reason couldbe the fact
that in DMEK procedure, sometimes a
splitting in Descemet membrane layers
occurs, leading to an adhesion of the
ABL on the recipient’s corneal stroma
and thus the extracted Descemet mem-
brane missed that specific layer (Weller
et al. 2016).
Even though the results of our
ex vivo study are promising, the fol-
lowing issues have to be addressed in
prospective studies. (1) Ab interno
ablation of guttae, corneal endothelium
and posterior Descemet membrane: in
our setting, ex vivo sclerocorneal rings
were mounted with the epithelium fac-
ing down to approach the corneal
endothelium directly with a straight
laser tip. In vivo, we propose difficulties
in ensuring an even ablation of the
endothelium when entering the eye via
a limbal corneal incision. A possible
solution would be a distance-fixed,
curved or bent laser tip. This is on
one hand important to maintain a flat
scaffold for endothelial cells to recolo-
nize the ablated area. On the other
hand, an irregular posterior corneal
surface can lead to higher order aber-
rations and thus decreased visual acu-
ity (Yazu et al. 2018). In addition, a
control of ablation could be performed
by instilling trypan blue intracamerally
to stain the ablated area, which seems
challenging in severe FECD patients
with opaque corneas. (2) Excimer laser
specifications: typical excimer lasers in
ablative corneal surgery emit ultravio-
let light of a wavelength of 193 nm to
guarantee precise cuts and a minimum
of thermal distortion (Trokel et al.
1983), in comparison with the 308 nm
ab interno excimer laser used in our
experiments. Therefore, further inves-
tigations on the tissue response espe-
cially of the corneal guttae and
Descemet membrane to different light
wavelengths must be performed to
optimize the ablation effectivity and
minimalize potential collateral damage.
(3) Corneal endothelial recolonization:
our results on corneal recolonization
after excimer laser ablation were
acquired, using healthy human corneas
and under treatment with ripasudil.
However, in FECD patients, the
endothelial cell density is decreased
and thus the recolonization potential
may differ. Therefore, experiments on
FECD corneas and different sizes of
the ablated area are required to inves-
tigate the regenerative potential of
corneal endothelium following excimer
laser treatment of diseased corneas.
In summary, we could demonstrate
a promising experimental approach to
excise guttae and parts of the Descemet
membrane by excimer laser ablation,
which in turn enables corneal endothe-
lial cells to migrate easily onto the
wounded area. However, several
methodological problems have to be
solved in advance and in vivo studies
need to be performed. Advantages of
this novel technique for potential treat-
ment of FECD might be the avoidance
of a corneal graft in combination with
the creation of a wound that does not
present bare stroma, cannot initiate an
unfavourable stromal healing response
and may encourage faster cell migra-
tion over an intact basement mem-
brane.
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